Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-10-23-Speech-2-461-625"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20121023.45.2-461-625"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"−
After the European Court of Auditors presented its annual report for the financial year 2010, as part of its discharge procedure for the financial year 2010 the European Parliament’s Committee on Budgetary Control carried out its financial audit of the implementation of the European Union’s general budget in relation to the European Medicines Agency. The primary task of the Committee on Budgetary Control is to scrutinise and ensure that the EU budget is being implemented appropriately and effectively. The discharge report drew Parliament’s attention to the fact that several conflicts of interest at the Agency had recently come to light. In the interests of clearing these matters up and putting management of the Agency on a more efficient and economical footing, the committee recommended postponing granting of discharge in spring. At its late September sitting, the Committee on Budgetary Control presented its second report on discharge for the Agency in which it stated that it had found sufficient assurances that management of the Agency would in future comply with the rules. The committee decided to grant discharge. I supported the granting of discharge in the vote in both committee and plenary."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples